BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from ...

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?

Novo Nordisk has global metabolic leadership, an oral GLP-1 program, and a stock price below $50 after a retail-driven ...

Melatonin has become one of the most commonly used sleep aids for children worldwide, driven by its reputation as a natural and accessible remedy for insomnia.

A Democratic lawmaker is raising new concerns about a Food and Drug Administration program designed to drastically shorten ...

Parents of autistic children are clamoring for a prescription vitamin promoted by federal health officials. But there's ...

New treatments based on biological molecules like RNA give scientists unprecedented control over how cells function. But ...

Patient advocates are asking a federal appeals court to crack down on third-party vendors that obtain prescription drugs from overseas for U.S. patients, arguing the practice exposes them to unsafe ...

Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps Institute have designed a group of potential diabetes drugs that reprogram ...

Since September, 16 major drug companies have inked deals with the Trump administration to lower prices. But in January — the time of year when pharmaceutical companies typically roll out price hikes ...